Correlation Between Emergent Biosolutions and Harrow Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Harrow Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Harrow Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Harrow Health 8625, you can compare the effects of market volatilities on Emergent Biosolutions and Harrow Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Harrow Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Harrow Health.

Diversification Opportunities for Emergent Biosolutions and Harrow Health

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Emergent and Harrow is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Harrow Health 8625 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harrow Health 8625 and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Harrow Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harrow Health 8625 has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Harrow Health go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Harrow Health

Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 23.27 times more return on investment than Harrow Health. However, Emergent Biosolutions is 23.27 times more volatile than Harrow Health 8625. It trades about 0.07 of its potential returns per unit of risk. Harrow Health 8625 is currently generating about 0.09 per unit of risk. If you would invest  725.00  in Emergent Biosolutions on September 15, 2024 and sell it today you would earn a total of  123.00  from holding Emergent Biosolutions or generate 16.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Emergent Biosolutions  vs.  Harrow Health 8625

 Performance 
       Timeline  
Emergent Biosolutions 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.
Harrow Health 8625 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Harrow Health 8625 are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Harrow Health is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Emergent Biosolutions and Harrow Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Emergent Biosolutions and Harrow Health

The main advantage of trading using opposite Emergent Biosolutions and Harrow Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Harrow Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harrow Health will offset losses from the drop in Harrow Health's long position.
The idea behind Emergent Biosolutions and Harrow Health 8625 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules